Close Bookmark and Share This Page

Save to Browser Favorites / Bookmarks

Ask backflip blinklist BlogBookmark Bloglines BlogMarks Blogsvine BuddyMarks BUMPzee! CiteULike Connotea del.icio.us

Digg diigo DotNetKicks DropJack dzone Facebook Fark Faves Friendsite folkd.com Furl Google

Jamespot Jeqq Kaboodle kirtsy linkaGoGo LinkedIn Ma.gnolia Mister Wong Mixx MySpace Netvouz Newsvine

oneview OnlyWire PlugIM Propeller Reddit Segnalo Shoutwire Simpy Slashdot Surphace Sphinn Spurl

Squidoo StumbleUpon Technorati ThisNext Twitter Webride Windows Live Yahoo!

Email This to a Friend

  Link HTML: 

 Permalink: 

 If you like this then please subscribe to the RSS Feed.

Powered by Bookmarkify™

More »

U.S. drug firm Alkermes Inc (ALKS.O) said on Monday it had received a lot of interest in a 25 percent stake held by Elan (ELN.I) that will be up for grabs next year and would like to tempt European investors to buy at least some of it.

Elan sold its drug delivery business to Alkermes earlier this year for 500 million euros cash plus a 25 percent stake in Alkermes that Elan will reduce after a six-month lock up period.

Full article here

Regards,

Don